Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906

被引:13
作者
Nozaki, Miwako [1 ]
Kagami, Yoshikazu [2 ]
Machida, Ryunosuke [3 ,11 ]
Nakamura, Kenichi [3 ]
Ito, Yoshinori [2 ]
Nishimura, Yasumasa [4 ]
Teshima, Teruki [5 ]
Saito, Yoshihiro [6 ]
Nagata, Yasushi [7 ]
Matsumoto, Yasuo [8 ]
Akimoto, Tetsuo [9 ]
Hiraoka, Masahiro [10 ]
机构
[1] Dokkyo Med Univ, Dept Radiol, Saitama Med Ctr, Saitama, Japan
[2] Showa Univ, Dept Radiat Oncol, Sch Med, Tokyo, Japan
[3] Natl Canc Ctr, JCOG Data Ctr Operat Off, Dept Int Clin Dev, Tokyo, Japan
[4] Kindai Univ Hosp, Dept Radiat Oncol, Osaka, Japan
[5] Osaka Int Canc Inst, Dept Radiat Oncol, Osaka, Japan
[6] Saitama Canc Ctr, Div Radiat Oncol, Saitama, Japan
[7] Hiroshima Univ Hosp, Dept Radiat Oncol, Hiroshima, Japan
[8] Niigata Canc Ctr Hosp, Dept Radiat Oncol, Niigata, Japan
[9] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Chiba, Japan
[10] Japanese Red Cross Wakayama Med Ctr, Dept Radiat Oncol, Wakayama, Japan
[11] Natl Canc Ctr, JCOG Data Ctr Operat Off, Canc Res Adm & Support, Biostat Div,Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan
关键词
clinical trial; early breast cancer; breast-conserving surgery; hypofractionated whole breast irradiation; RADIOTHERAPY HYPOFRACTIONATION; UK STANDARDIZATION; CARDIAC MORTALITY; RADIATION-THERAPY; CANCER; WOMEN; RISK; FRACTIONATION;
D O I
10.1093/jjco/hyab024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To evaluate the safety and efficacy of hypofractionated whole breast irradiation for Asian women after breast-conserving surgery. This is an updated report with 5-year follow-up. Methods and materials: Asian women who had invasive breast cancer with clinical tumor size <= 3 cm, pN0-1c and negative inked margins were enrolled. Hypofractionated whole breast irradiation of 42.56 Gy/16 fractions was delivered, and boost irradiation of 10.64 Gy/4 fractions was added when the surgical margin was <= 5 mm. The primary endpoint was the proportion of grade >= 2 late adverse reactions within 3 years. Secondary endpoints included early adverse events, overall survival, disease-free survival, ipsilateral breast relapse-free survival, late adverse reactions and cosmetic outcome. Toxicities were evaluated using CTCAE ver3.0. Cosmetic outcomes were assessed using a 4-point scale and CTCAE ver3.0 for hyper/hypopigmentation, breast nipple/areolar deformity and breast volume/deformity. Results: Between February 2010 and August 2012, 312 patients were enrolled, and 306 received hypofractionated whole breast irradiation. Median follow-up was 70.5 (range 7.6-88.9) months. The proportion of grade >= 2 late adverse reactions within 3 years was 4.3% (90% confidence interval 2.5-6.7%). Grade 2 early adverse events occurred in 38 (12.4%); none had grade 3/4. Five-year overall survival, disease-free survival and ipsilateral breast relapse-free survival were 98.7, 95.4 and 98.0%, respectively. Of the 304 evaluable patients, 29 (9.5%; 95% confidence interval 6.5-13.4%) had grade 2/3 late adverse reactions; none had grade 4/5. At 5 years, 70/289 (24.2%) showed any worsening of breast cosmetic changes. Conclusions: Hypofractionated whole breast irradiation is considered a standard treatment for Asian women with margin-negative invasive breast cancer after breast-conserving surgery.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 22 条
[1]  
[Anonymous], 2016, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD003860.PUB4
[2]  
Ash D V, 1995, Clin Oncol (R Coll Radiol), V7, P93, DOI 10.1016/S0936-6555(05)80808-8
[3]  
Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7
[4]  
Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]
[5]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[6]   Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO) [J].
Duma, Marciana-Nona ;
Baumann, Rene ;
Budach, Wilfried ;
Dunst, Juergen ;
Feyer, Petra ;
Fietkau, Rainer ;
Haase, Wulf ;
Harms, Wolfgang ;
Hehr, Thomas ;
Krug, David ;
Piroth, Marc D. ;
Sedlmayer, Felix ;
Souchon, Rainer ;
Sauer, Rolf .
STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (10) :861-871
[7]   Frontiers in Radiotherapy for Early-Stage Invasive Breast Cancer [J].
Fisher, Christine M. ;
Rabinovitch, Rachel .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26) :2894-2901
[8]   The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials [J].
Haviland, Joanne S. ;
Owen, J. Roger ;
Dewar, John A. ;
Agrawal, Rajiv K. ;
Barrett, Jane ;
Barrett-Lee, Peter J. ;
Dobbs, H. Jane ;
Hopwood, Penelope ;
Lawton, Pat A. ;
Magee, Brian J. ;
Mills, Judith ;
Simmons, Sandra ;
Sydenham, Mark A. ;
Venables, Karen ;
Bliss, Judith M. ;
Yarnold, John R. .
LANCET ONCOLOGY, 2013, 14 (11) :1086-1094
[9]   Tumour bed boost radiotherapy for women after breast-conserving surgery [J].
Kindts, Isabelle ;
Laenen, Annouschka ;
Depuydt, Tom ;
Weltens, Caroline .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11)
[10]   Risk factors for radiation pneumonitis caused by whole breast irradiation following breast-conserving surgery [J].
Kubo, Akiko ;
Osaki, Kyosuke ;
Kawanaka, Takashi ;
Furutani, Shunsuke ;
Ikushima, Hitoshi ;
Nishitani, Hiromu .
JOURNAL OF MEDICAL INVESTIGATION, 2009, 56 (3-4) :99-110